Yang J, Zhao B, Ling X, Li D, et al. Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China. BMC Cancer 2023;23:103.
PMID: 36717797